It is occasionally observed that common sporadic diseases have rare familial counterparts in which mutations at a single locus result in a similar disorder exhibiting simple Mendelian inheritance. Such an observation is often sufficient justification for the creation of a disease model in the fly. Whether the system is based on the over-expression of a toxic variant of a human protein or requires the loss of function of an orthologous fly gene, the consequent phenotypes can be used to understand pathogenesis through the discovery of genetic modifiers. Such genetic screening can be completed rapidly in the fly and in this review we outline how libraries of mutants are generated and how consequent changes in disease-related phenotypes are assessed. The bioinformatic approaches to processing the copious amounts of data so generated are also presented. The next phase of fly modelling will tackle the challenges of complex diseases in which many genes are associated with risk in the human. There is growing interest in the use of interactomics and epigenetics to provide proteome-and genome-scale descriptions of the regulatory dysfunction that results in disease.
INTRODUCTION
During the last decade over a hundred invertebrate and vertebrate genome sequences have been published [1] . This flood of sequence data is the result of remarkable advances in sequencing technology; however, in many cases data acquisition has leapt ahead of our ability to understand the function of much of the genome in health and disease. In many cases even though we do not know the function of a particular stretch of DNA, we may nevertheless infer its importance because similar sequences are observed in organisms that last shared a common ancestor many millions of years ago. Indeed one of the profound lessons of the genomic era has been how similar different organisms are at the molecular level [2] . It is this profound genetic orthology between species, even between mammals and invertebrates, which underpins the use of Drosophila to study human disease.
Historically, invertebrate models of human disease have been based on selected human syndromes where the pathogenesis is unusually clear. Typically the disorders are inherited in a Mendelian manner and single gene defects have already been identified in humans. Examples include the expanded polyglutamine stretches that underpin Huntington's disease, the mutations that increase the aggregation of the amyloid-b peptide in Alzheimer's disease or the kinase mutations that are responsible for promoting cancer proliferation. Such clear genetic aetiology is usually seen only in relatively rare familial conditions that happen to share clinical similarities with the common sporadic diseases. Indeed it is the simplicity of the underlying genetic defects that allows us to replicate the analogous pathology in Drosophila model systems. Such fly models often exhibit whole-organism phenotypes that are concordant in many ways with the symptoms and signs observed in affected humans. Classically these fly models are used as a tool to investigate the genes responsible for a disease; in practice this means that we up-or down-regulate genes in the fly and find which modifications enhance or suppress disease-relevant phenotypes. This sort of work constitutes the bulk of publications in the field to date; however, more significant challenges are now being faced as we interpret the results of genetic studies in the more common sporadic forms of disease. Such challenging data come from large-scale genome-wide association studies that have successfully illuminated some of the genetic complexity underpinning sporadic disorders. A good example is sporadic Alzheimer's disease where the number of genes carrying risk is likely to exceed 10 [3] ; furthermore in this case there is little or no overlap between genes that cause familial, and those that cause sporadic, disease. Such revelations have left many investigators uncertain about how to faithfully reconstruct the most fundamental pathogenic pathways in a fly model system, indeed when faced with the variety of underlying genes one may wonder whether Alzheimer's disease, for example, could be more than a single disease. Finding how to model the various facets of multi-gene disorders is a current problem that may need the genome-scale power of invertebrate systems to facilitate progress in understanding pathways and finding therapeutic targets.
The fruit fly has proven an ideal model organism for studying a range of human diseases for a number of reasons, not least among these are the short lifespan and the powerful genome-scale toolkits that are available, including deficiency (deletion), RNA interference (RNAi) and over-expression libraries. Advances in bioinformatic analysis have also been necessary to allow us to interpret the results of classical disease modelling in the fly and such techniques are likely to be even more important in the genomic era.
GENERAL APPROACHES AND ADVANTAGES OF DROSOPHILA HUMAN DISEASE MODEL
While the fly is phylogenetically further from the human than other model organisms such as fish and rodents, what it loses in biological similarity it gains in speed and power. In many ways the fly offers the advantages of cell culture with the extra bonus of having a tissue-and whole-organism context for the biological results. Broadly speaking, three kinds of diseases have successfully utilize Drosophila as a model system, including neurological disorders, particularly of old age, cancer and metabolic disorders ( Figure 1 ). Such models have been established by either generating mutations in endogenous Drosophila genes that mimic disease-linked mutations in humans; or else over-expressing wild-type, or pathogenic variants of, disease-linked human genes and looking for associated phenotypes.
Typically, for fly models of neurological disease, behavioural assays provide convenient measures of brain and nerve function. For example, the investigator can conveniently quantify the bang sensitive convulsions and neuronal dysfunction that result from mutation of the Drosophila kcc gene, which cause hyperactivation of GABAnergic post-synaptic neurons. Reduced expression of the orthologous K þ Cl À co-transporter (kcc2) is found in some patients with temporal lobe epilepsy [4] and this functional conservation allows us to use the fly to model a disorder that is unlikely to be satisfactorily modelled in cell culture [5, 6] . In addition Drosophila have been widely used for the study of neurodegenerative disorders, such as Huntington, Alzheimer and Parkinson diseases, that result primarily from protein aggregation [7, 8] . In these model systems, assays of neuronal anatomy, longevity, locomotor behaviour, learning and memory have been developed to help us identify toxic protein aggregates.
On the other hand, fly models of carcinogenesis rely more heavily on phenotypes that report aberrations in tissue growth and development. In this regard abnormalities in eye morphogenesis and wing vein patterning are derived from misregulation of cell differentiation, growth and adhesion control and at least for models of the EKR [9] and Wnt [10] pathways have provided mechanistic insights (see list of disease-related phenotypes in Figure 1 ).
More recently, a genome-wide study screened for alterations in the triglyceride content in Drosophila to identify genes controlling lipid metabolism and obesity [11] . Increased fat content also results in increased buoyancy and this has been screened against in order to identify genes regulate the total fat level [12] .
For a comprehensive view, the Bloomington stock centre provides access to a wide range of fly disease model resources (http://fly.bio.indiana.edu/ Browse/HD/HDintro.htm). In this review however, rather than document the diverse fly models of disease (reviewed in [13] ) we will instead give examples of the various functional genomics tools that are available in Drosophila that can help us to understand human disease at a genome level.
GENOMICS TOOLS IN DROSOPHILA Bioinformatics tools
The bioinformatic challenges faced by functional genomics investigators centre around the need to integrate large datasets and draw informative conclusions. In this section we will introduce some essential online services that are commonly used in the analysis of genomics data from Drosophila disease model systems. Flybase is the most frequently used database in the fly research community (http://flybase.org/, [14] ). On the Flybase website, the bulk of the data is structured around individual Drosophila genes. Typically there are links that describe over-expression and deficiency phenotypes, there are gene structure diagrams, expression profile data, interaction maps, information regarding transcriptional regulation and links to gene orthologues across various taxa. In many cases much can be gained from cross-species analysis of genomic data. A particular example is the Homophila resource (http://superfly.ucsd.edu/homophila/, [15] ) that compares fly gene sequences in Flybase with the Online Mendelian Inheritance in Man (OMIM) database that is hosted by the National Center for Biotechnology Information (http://www.ncbi.nlm. nih.gov/omim). There are a number of more general purpose orthologue databases that appeal to disease modellers, for example both the orthodisease, (http://orthodisease.sbc.su.se/, [16] ) and DIOPT-DIST (http://www.flyrnai.org/diopt-dist, [17] ) list orthologues of disease-linked genes across many species. Furthermore, InParanoid provides an all Modified from [17, 85] for (A), [5, 36, 86] for (B) and [11, 12] for (D). The Drosophila image was sourced from the Flybase Image gallery.
purpose multi-species database of gene orthologues (http://inparanoid.sbc.su.se/cgi-bin/index.cgi, [18] ).
Genetic screens
Many important human diseases, such as diabetes and Alzheimer's disease show high heritability and this observation provides the chief justification for undertaking genetic modifier screens in a Drosophila model system. Such genome-wide gene surveys may help in two main ways. First, by finding which Drosophila genes can modify the severity of disease-related phenotypes in the fly we hope to predict which orthologous human genes may modulate disease risk or severity in patients. Second, even when the orthologous human genes do not carry risk for the human disease it may nevertheless be possible to detect which biological processes are particularly important in phenotype generation by looking for over-represented biological functions within the set of phenotype-modifying genes.
Over the past 10 years the fly community has generated many thousands of fly strains for genetic screening experiments, each with unique causes of genetic diversity. In the past chemical or X-ray mutagenesis was the predominant approach for introducing genetic variation, however the labour required to identify which mutation was responsible for phenotype modulation was significant and often limited progress. Consequently, screens in which P-element transposon insertions are used to dysregulate gene expression or cause deletions have become more popular (see reviews [19, 20] ). P-element screens are quicker because the known sequence of the mutagenic construct can be used to rapidly locate the site of insertion. However with the advent of rapid genomic sequencing the use of chemical and X-ray mutagenesis may return to prominence because the process of detecting the modifying mutations has become much quicker and easier [21] .
No matter how the genetic diversity in a library is generated, each modifier screen shares a number of common features. Typically, each genetic variation is introduced into a fly that exhibits a disease-related phenotype and the consequent severity is assessed (Figure 2) . If the phenotypes become more or less strong in the presence of the genetic variation then the screen has generated a hit provided that control experiments indicate that the effects are disease-specific. Typical control experiments involve the introduction of the same genetic variation into a control line of flies that do not exhibit disease phenotypes, thus allowing the detection of any non-specific effects. Deficiency and P-element screen (organism level) P-element mobilization around the fly genome can be used to modify gene expression in a number of ways, these include the disruption of regulatory DNA sequences, interruption of exons and changing splicing patterns. When flies with P-elements at different positions in the genome are crossed it is also possible to generate specific deletions through homologous recombination [20] . The systematic generation of deletions is now possible using libraries of flies carrying specific P-element inserts, these collections, called deficiency kits, have good coverage of Drosophila genome [22] [23] [24] [25] [26] .
In most cases the genetic disruptions described above result in reduced or absent gene function. These libraries have been used to identify diseaserelated genes or their modifiers in fly model of obesity [12, 27] and Parkinson's disease model [28] , poly-glutamine mediated neurotoxicity [29] and Alzheimer's disease [30] .
Screening gene over-expression An alternative strategy for discovering genetic modifiers is to over-express genes rather than disrupt their expression. This approach possesses the technical advantage that over-expression phenotypic effects are more often inherited in a dominant manner. This means that the yield of hits from the screen may be higher and the screen itself can be performed more rapidly. However most conceivable therapies for disease result a reduction in target protein function and so over-expression screens may not generate potential drug targets any more effectively.
Over-expression in the fly is typically achieved by inserting a gal4 upstream activating sequence (UAS) 5 0 to the target gene. Of itself this modification will not result in gene over-expression, for this we need to also express the yeast gal4 transcriptional activator in the required tissue [31] . Strains of flies that express gal4 are called 'driver lines' and when combined with the gal-UAS construct they determine the distribution of enhanced protein expression. Gal4-UAS sequences can be inserted pseudo-randomly throughout the genome by mobilizing a particular series of P-elements termed EP-and GS-elements. These transposon-like constructs usually activate gene expression unidirectionally (EP elements [25] ) or bidirectionally (GS elements [32] ) from their point of insertion (Figure 2 ). However such traditional approaches to transposon-mediated mutagenesis [40] are not entirely unbiased because the vectors have a marked preference for insertion in the 5 0 -region of genes [41] . In response to this limitation the Minos transposon has been developed and has been shown to have a less biased distribution of insertion sites [40, 42] . On the other hand, the development of recombineering and the Phi31C system (P[acman], see [43] ) makes it possible to insert specific DNA fragment (up to $100 Kb) into a pre-defined locus, and therefore provides an unbiased strategies for gene duplication. Libraries of fly lines that carry UAS element inserted throughout the genome are available from major stock centres, including Bloomington (http://fly.bio.indiana.edu/) and Kyoto (http:// kyotofly.kit.jp/cgi-bin/stocks/index.cgi).
Screens using these libraries or novel lines have successfully identified novel genetic enhancers or suppressors related to human diseases, such as in cell outgrowth control [33] , lifespan determination [34] , epilepsy [35] and neuronal degeneration [36] [37] [38] [39] .
Using RNAi expression to knockdown gene expression
Drosophila are a particularly useful host for RNAi experiments because target knockdown can achieved by large RNA hairpin fragments (300-400 bp) without inducing an unwanted interferon response [44, 45] . Knockdown may be performed in Drosophila cell culture and this allows for highthroughput screening for proxy markers of disease such as changes in oncogenic RTK/ERK signalling [9] , cell growth [46] and cell cycle [47] , modifiers for poly-glutamine derived aggregation [48] and neurotoxicity [49] , and host factors for intracellular bacterial infection [50] . Such first-line results can be conveniently refined by taking candidates forward to model systems in the whole fly. This can be achieved using whole-genome libraries that permit tissue-and age-specific expression of RNAi constructs in the fly using the gal4-UAS system.
Three major stock centres, the Vienna Drosophila RNAi collection (VDRC; http://stockcenter.vdrc. at/control/main) [51] , National Institute of Genetics (NIG) collection (http://www.shigen.nig. ac.jp/fly/nigfly/index.jsp) and Transgenic RNAi Project at Harvard Medical School (TRiP) (http:// www.flyrnai.org/TRiP-HOME.html) have established libraries of UAS-RNAi fly strains that cover more than 90% of Drosophila genes. These two resources have been used to verify the results from cell-based screens and to investigate the effects of knocking down candidate genes [45] .
Whereas many whole-genome RNAi screens have been performed to study fundamental biological processes including cell signalling, hypoxia stress, innate immune system, pain sensory and neuronal development [52] [53] [54] [55] [56] , such screens have not been undertaken systematically in disease models. The few examples include studies in obesity [11] , cardiac function [54] and bacterial infection [57] . Recently, the online database GenomeRNAi has documented most of the genome-wide cell based and in vivo RNAi screens (http://genomernai.de/ GenomeRNAi/, [58] ).
Despite its unbiased, whole-genome approach and the capacity for high-throughput screening, the results from RNAi modifier screens usually require verification by other genetic manipulations. Confidence in a finding is often increased by using a second RNAi construct that is targeted to another part of the transcript. If the effects are of the two RNAi lines are consistent then the chances that they are due to off target effects are reduced; likewise gene knockdown caused by a deletion or P-element gene disruption may also provide support [59] . In addition, the in vivo efficiency of gene knockdown is influenced by the levels of the RNAi and consequently by the genomic site of the UAS-RNAi insertion. This variability in RNAi levels is an important variable to consider when using the GD collection from VDRC or NIG. The KK collection at VDRC has overcome the problem of variability by ensuring that the expression constructs are all inserted at the same genomic locus; however in these lines the absolute levels of RNAi are often lower and so efficient knockdown may require co-expression with the Dicer enzyme.
Transcriptomics
In many ways transcriptome analysis in fly disease models provides complementary data to the gene manipulation approaches described above. Rather than taking a disease model and actively modifying it, instead we ask what changes in mRNA levels occur in response to the disease insult. In practice, whether changes in transcript levels constitute the cause of a particular disease-related phenotype, or rather a consequence, is often not clear. However the lists of genes that is up-or down-regulated in response to the disease phenotypes can be analysed for enrichment in various ontology attributes such as biological function, cellular localization and biochemical activity. This analysis helps the investigator to estimate the relative importance of a number of biological pathways in the disease and these data may guide further investigations. For example, we analysed the transcriptome in our fly model of Alzheimer's disease at various ages and found that genes related to oxidative stress were notably up-regulated in diseased versus control flies (Rival 2009 ).
Tissue specific analysis of gene expression is now possible for the fly and this has enabled FlyAtlas (http://flyatlas.org/, [60] ) to map the sites of expression of genes that are derived from the Homophila database. These tissue-specific lists of fly orthologues of disease-related human genes provide a rational approach for identifying candidate genes for further screening in particular model systems. For example when investigating neurodegenerative disease the candidate gene list might consist of all the fly orthologues of human pathogenic genes that also happen to be transcribed in the brain.
The combined use of gene manipulation with transcriptome analysis has generated data for a number of disease model systems, including renal disease [61] , epilepsy [35] , Parkinson's diseases [62] , polyglutamine [63] , Alzheimer's disease [36] and repeated RNA toxicity [64] ). Notably a comparative genomic approach was integrated to identify taupathy regulators by parallel screens using tau mutant mouse brain RNA microarray and the fly rough eye modifier [65] (see below sections for similar strategy for interactomics).
The classical approach for genome-wide transcriptome analysis relies on DNA/RNA hybridization-based microarray technology that has been designed for use with Drosophila. However, these hybridization based microarrays are relatively insensitive to small changes in gene expression and so provide only a semi-quantitative profile. Recently, next-generation sequencing technology has reduced the financial and time costs of genomic and transcriptome sequencing [66] . One expects that this technology will in the future provide rapid and complete analysis of disease-related genetic variability in model systems [66] . In Drosophila, in particular, RNA direct-sequencing has provided a quantitative expression profile of protein-coding and non-coding RNAs and their splicing variants from different developmental stages [67] [68] [69] . Whereas transcriptome sequencing has been used to identify regulators in disease models in the mouse [70] , this approach has not been widely undertaken in fly disease models.
Proteomics and interactomics
Of course the role of protein-coding genes in disease cannot be understood simply in terms of the sequence and abundance of their respective DNA and RNA polynucleotides. Rather it is proteins that usually exert biological effects and so a complete understanding of a disease requires us to discover how relevant proteins interact with each other. Accordingly, the science of interactomics seeks to understand the web of protein-protein interactions, that in health comprises a functional control network, but that go awry in disease. The first interactomes used yeast two-hybrid (Y2H) data to map interactions between proteins encoded by a Drosophila cDNA library. This approach proved reasonable for many cytoplasmic proteins whereas it under-represented interactions with membrane proteins due to the nature of the technology [71] . More comprehensive protein interactomes were established by generating flies [72] or cultured cells [73] that express peptide-tagged endogenous proteins and then using co-immunoprecipitation and mass spectrometry (MS) to identify interactors.
Whole-proteome interaction data is available for the fly from online databases such as BioGRID (http://thebiogrid.org/, [74] ) and DroID (http:// droidb.org/, [75] ), however a recent study used a 'mini-interactome' to focus on a particular biological process. Specifically Friedman and colleagues chose the RTK-ERK pathway because of its importance in cancer cell signalling and the previous work that has shown it to be composed of a core set of proteins. Using 15 members of the pathway as bait they identified a large set of interacting proteins by MS in Drosophila S2 cell cultures. This group of proteins was validated by a series of whole-genome RNAi screens that used ERK phosphorylation as the readout under six conditions that were likely to change the activity of the RTK-ERK pathway. The overlap between the results of the RNAi screens and the MS interactome included many genes that were already known to be involved in the RTK-ERK pathway; notably there was also a previously unknown regulator (TepIV) that has been observed to be mutated in human cancers [17] .
As well as generating the primary screen data, the fly is often used for final candidate validation in broader interactomics experiments. A notable example is a study in which Kaltenbach set out to identify functionally important interactors for the pathogenic form of huntingtin. They generated a list of 234 huntingtin interactors using two approaches: firstly they screened a human cDNA library using a yeast two hybrid assay; secondly, they used mass spectroscopy to identify pulled-down proteins from mouse and human brain extracts and from mouse muscle extracts. The sixty fly orthologues of these candidate interactors were then screened for their ability to modify the retinal neurodegeneration that accompanies expression of pathogenic huntingtin. Fully 48 out of 60 of the orthologues exhibited modifier activity when either over-expressed or partially knocked-down in this model system. By combining interactomics with functional genetic screening in the fly the investigators increased the modifier detection rate $50-fold and by pre-screening in mammalian systems they increased the confidence that the findings will be relevant to human disease [76] .
Epigenetics and disease models in flies
The physiological and pathological control of gene expression is typically mediated by non-coding DNA that binds regulatory proteins. Such DNA-binding sites include promoters, enhancers, DNA replication sites and transcription factor targets. A further level of control is also available to the cell because changes in chromatin structure can regulate the accessibility of these DNA target sequences. In particular, histone acetylation can disturb chromatin packing and so facilitate access whereas histone methylation usually has the opposite effect. The binding of regulatory proteins to their DNA targets, and the distribution of histone modifications, can now be determined at the genome scale. Instead of assessing protein-DNA interactions by chromatin-immunoprecipitation (ChIP) or electrophoretic mobility shift assays (EMSA), better throughput may be achieved in two ways. The first, ChIP on chip, seeks to co-immunoprecipitate DNA fragments along with particular DNA-binding proteins. The identity of the co-purified DNA is then determined by annealing to a chip. The second approach, ChIP-seq, uses next generation DNA sequencing to positively identify each DNA molecule present in the coimmunoprecipitate.
There is however considerable uncertainty as to the degree of epigenetic orthology between fly and man. While our overall level of knowledge is low there have been some studies in which disease-relevant insights have been made. Notably, cancer cells are well known to have aberrant epigenetic profiles and there is evidence that changes such as histone methylation may contribute to the carcinogenesis. In this regard the polycomb group proteins (PcG) is of interest because of its ability to silence gene transcription following its recruitment to insulator sequences in the genome [77] . In fly models, the mutation of PcG components results in abnormal epithelial outgrowth due to over-activation of the JAK-STAT pathway. This work supports a tumour suppressor role for the polycomb complex [78] . Furthermore, a recent genome-wide prediction of PcG-binding targets implicated an excess of genes that are involved in development and cell fate determination [79] . A similar tumour suppressor role has also been proposed for another insulator-binding protein, L(3)mbt. This factor also down-regulates a number of signalling genes including members of the JAK-STAT pathway. Mutations in Drosophila L(3)mbt have been shown by ChIP-sequencing to lose their insulator-binding activity and are also associated neuroepithelial proliferation in the fly [80] . These observations are all the more impressive because deletion of the orthologous gene L3MBTL3 is observed in a subset of human neuroblastomas.
The normal development of the nervous system is also regulated by epigenetic mechanisms that appear to be conserved between humans and flies. For example a rare human neurodevelopmental disorder called Kleefstra Syndrome. In humans this condition is caused by the deletion of euchromatin histone methyltransferase (EHMT) and so Kramer and colleagues deleted the orthologous gene in flies and looked for changes in epigenetic markers. When they looked at the genes that were affected by the consequent loss of EHMT-specific H3K9 histone dimethylation is became clear that there was a significant enrichment in classic genes involved in learning and memory [81] .
A comprehensive collection of DNA-binding and chromatin-modification data, along with functional correlates, is being undertaken by the Encyclopaedia Of DNA Elements (ENCODE, [82] ) and modENCODE [83] ) projects for human and model organism genomes. Remarkably, the Drosophila modENCODE data now allows us to identify cell type and developmentally regulated chromatin states by considering histone methylation and acetylation as along with binding profiles for transcription factors [69] . The systematic application of epigenetics in the understanding of human disease through fly modelling requires genome-scale bioinformatics resources. Work in this regard has been undertaken by the DAnCER project (http:// wodaklab.org/dancer/, [84] ). By collating the association of chromatin modifications with disease and by predicting the binding of regulatory proteins to genes this resource helps the investigator assess the likely functional consequences of changes in transcription factors and other proteins involved in epigenetic regulation.
PERSPECTIVES
With time, the goals of the Drosophiladisease-modelling community have changed. Initially we simply generated disease-related phenotypes in flies and then used models of simple Mendelian disorders to find what other genes are implicated in disease pathogenesis. The next challenge is to use the power of genomic scale tools to understand the mechanisms underpinning the common sporadic diseases that show complex, multi-gene inheritance.
Key points
Drosophila are typically employed to model Mendelian disorders either by (i) the knockdown of fly genes orthologues human disease genes or (ii) by the over-expression of disease-linked human transgenes. Modifier screens and transcriptome analysis are then used to understand the biological pathways involved in either (i) generating disease-related phenotypes or (ii) responding to the pathogenic insult. Common diseases often have several genes that carry risk and genome-or proteome-wide analysis may be needed to unravel disease mechanisms; the fly is a convenient model system for these types of studies. Bioinformatic analysis of large datasets is important in this field and some resources are outlined. 
